Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,208 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT03829254

Conditions
Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust (Addenbrookes Hospital) Cambridge, United Kingdom
  • Edinburgh Cancer Centre, Western General Hospital Edinburgh, United Kingdom
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details
Recruiting

ACTengine® IMA203 Combined With mRNA-4203

NCT06946225

Conditions
Cutaneous Melanoma, Melanoma, Neoplasms, +15 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma

NCT05428007

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • The Angeles Clinic at Cedars Sinai Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU Langone Health New York, United States
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details

Related conditions